Issues related to the treatment of rare diseases.
2025 · 1st Quarter (Jan 1 - Mar 31)
BRIDGEBIO PHARMA, INC.
Filed by THORN RUN PARTNERS.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Termination
- Posted
- Mar 13, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- THORN RUN PARTNERS
- Client
- BRIDGEBIO PHARMA, INC.
- Filing UUID
- 7b1576d0-75c9-4f8e-9ea1-304ed8d44cae
- Termination date
- Mar 1, 2025
Literal source text
Lobbying issues and bill citations
Issues related to the treatment of rare diseases.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.